SUMMARY
Zydus Cadila Healthcare Limited (Zydus Cadila) is a global pharmaceutical company. It discovers, develops, manufactures and markets a broad portfolio of healthcare products. The company has extensive operations comprising active pharmaceutical ingredients (APIs), formulations, cosmeceuticals and animal health products. The products of Zydus Cadila targets various therapeutic applications, including gastrointestinal, cardiovascular, women's healthcare, respiratory, pain management, central nervous system, anti-infectives, cancer, and diseases related to neurology, dermatology and nephrology.
Zydus Cadila Healthcare Limited Key Recent Developments
Feb 08, 2013: Cadila Healthcare Reports Revenue Of INR15.6 Billion In Q3 Fiscal 2013
Nov 07, 2012: Cadila Healthcare Reports Revenue Of INR15.1 Billion In Q2 Fiscal 2013
Aug 06, 2012: Cadila Healthcare Reports Revenue Of INR15.2 Billion In Q1 Fiscal 2013
Jul 17, 2012: FDA Withdraws Earlier Warning Letter Issued To Cadila Healthcare
May 10, 2012: Cadila Healthcare Reports Revenue Of INR13.4 Billion In Q4 Fiscal 2012
This comprehensive SWOT profile of Zydus Cadila Healthcare Limited provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better
The profile contains critical company information including:
KEY BENEFITS OF BUYING THIS PROFILE INCLUDE:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Zydus Cadila Healthcare Limited (Zydus Cadila) is a global pharmaceutical company. It discovers, develops, manufactures and markets a broad portfolio of healthcare products. The company has extensive operations comprising active pharmaceutical ingredients (APIs), formulations, cosmeceuticals and animal health products. The products of Zydus Cadila targets various therapeutic applications, including gastrointestinal, cardiovascular, women's healthcare, respiratory, pain management, central nervous system, anti-infectives, cancer, and diseases related to neurology, dermatology and nephrology.
Zydus Cadila Healthcare Limited Key Recent Developments
Feb 08, 2013: Cadila Healthcare Reports Revenue Of INR15.6 Billion In Q3 Fiscal 2013
Nov 07, 2012: Cadila Healthcare Reports Revenue Of INR15.1 Billion In Q2 Fiscal 2013
Aug 06, 2012: Cadila Healthcare Reports Revenue Of INR15.2 Billion In Q1 Fiscal 2013
Jul 17, 2012: FDA Withdraws Earlier Warning Letter Issued To Cadila Healthcare
May 10, 2012: Cadila Healthcare Reports Revenue Of INR13.4 Billion In Q4 Fiscal 2012
This comprehensive SWOT profile of Zydus Cadila Healthcare Limited provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
KEY BENEFITS OF BUYING THIS PROFILE INCLUDE:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
SECTION 1 - ABOUT THE COMPANY
Zydus Cadila Healthcare Limited - Key Facts
Zydus Cadila Healthcare Limited - Key Employees
Zydus Cadila Healthcare Limited - Key Employee Biographies
Zydus Cadila Healthcare Limited - Major Products and Services
Zydus Cadila Healthcare Limited - Pharmaceutical Pipeline Products Data
Zydus Cadila Healthcare Limited, Pipeline Products by Therapy Area
Zydus Cadila Healthcare Limited, Pipeline Products by Development Phase
Zydus Cadila Healthcare Limited - History
Zydus Cadila Healthcare Limited - Company Statement
Zydus Cadila Healthcare Limited - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
SECTION 2 – COMPANY ANALYSIS
Zydus Cadila Healthcare Limited - Business Description
Zydus Cadila Healthcare Limited - Corporate Strategy
Zydus Cadila Healthcare Limited - SWOT Analysis
SWOT Analysis - Overview
Zydus Cadila Healthcare Limited - Strengths
Strength - Operational Base: Vertical Integration
Strength - Product and Brand Portfolio
Strength - Leading Market Position
Zydus Cadila Healthcare Limited - Weaknesses
Weakness - Weak Operational Efficiency
Weakness - Trade Receivables
Zydus Cadila Healthcare Limited - Opportunities
Opportunity - Investments: New Technologies
Opportunity - Growth Prospects: Emerging Markets
Opportunity - Acquisitions and Agreements
Zydus Cadila Healthcare Limited - Threats
Threat - Competitive Landscape
Threat - Uncertain R&D Activities
Threat - Stringent Government Regulations
Zydus Cadila Healthcare Limited - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
Zydus Cadila Healthcare Limited, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Zydus Cadila Healthcare Limited, Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013
Zydus Cadila Healthcare Limited, Medical Equipment, Deals By Year, 2007 to YTD 2013
Zydus Cadila Healthcare Limited, Medical Equipment, Deals By Type, 2007 to YTD 2013
Zydus Cadila Healthcare Limited, Recent Deals Summary
SECTION 5 – COMPANY’S RECENT DEVELOPMENTS
Zydus Cadila Healthcare Limited, Recent Developments
Feb 08, 2013: Cadila Healthcare Reports Revenue Of INR15.6 Billion In Q3 Fiscal 2013
Nov 07, 2012: Cadila Healthcare Reports Revenue Of INR15.1 Billion In Q2 Fiscal 2013
Aug 06, 2012: Cadila Healthcare Reports Revenue Of INR15.2 Billion In Q1 Fiscal 2013
Jul 17, 2012: FDA Withdraws Earlier Warning Letter Issued To Cadila Healthcare
May 10, 2012: Cadila Healthcare Reports Revenue Of INR13.4 Billion In Q4 Fiscal 2012
Apr 02, 2012: Karo Bio's Collaboration With Zydus Cadila Expires
Feb 07, 2012: Cadila Healthcare Reports Net Sales Of INR13.5 Billion In Q3 Fiscal 2012
SECTION 6 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
LIST OF TABLES
Zydus Cadila Healthcare Limited, Key Facts
Zydus Cadila Healthcare Limited, Key Employees
Zydus Cadila Healthcare Limited, Key Employee Biographies
Zydus Cadila Healthcare Limited, Major Products and Services
Zydus Cadila Healthcare Limited, Number of Pipeline Products by Therapy Area
Zydus Cadila Healthcare Limited, Number of Pipeline Products by Development Stage
Zydus Cadila Healthcare Limited, Pipeline Products By Therapy Area and Development Phase
Zydus Cadila Healthcare Limited, History
Zydus Cadila Healthcare Limited, Subsidiaries
Zydus Cadila Healthcare Limited, Joint Venture
Zydus Cadila Healthcare Limited, Key Competitors
Zydus Cadila Healthcare Limited, Ratios based on current share price
Zydus Cadila Healthcare Limited, Annual Ratios
Zydus Cadila Healthcare Limited, Interim Ratios
Zydus Cadila Healthcare Limited, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Zydus Cadila Healthcare Limited, Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013
Zydus Cadila Healthcare Limited, Medical Equipment, Deals By Year, 2007 to YTD 2013
Zydus Cadila Healthcare Limited, Medical Equipment, Deals By Type, 2007 to YTD 2013
Zydus Cadila Healthcare Limited, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
LIST OF FIGURES
Sarepta Therapeutics, Inc., Pipeline Products by Therapy Area
Sarepta Therapeutics, Inc., Pipeline Products by Development Phase
Sarepta Therapeutics, Inc., Performance Chart (2007 - 2011)
Sarepta Therapeutics, Inc., Ratio Charts
Sarepta Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Sarepta Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2007 to YTD 2013
Zydus Cadila Healthcare Limited - Key Facts
Zydus Cadila Healthcare Limited - Key Employees
Zydus Cadila Healthcare Limited - Key Employee Biographies
Zydus Cadila Healthcare Limited - Major Products and Services
Zydus Cadila Healthcare Limited - Pharmaceutical Pipeline Products Data
Zydus Cadila Healthcare Limited, Pipeline Products by Therapy Area
Zydus Cadila Healthcare Limited, Pipeline Products by Development Phase
Zydus Cadila Healthcare Limited - History
Zydus Cadila Healthcare Limited - Company Statement
Zydus Cadila Healthcare Limited - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
SECTION 2 – COMPANY ANALYSIS
Zydus Cadila Healthcare Limited - Business Description
Zydus Cadila Healthcare Limited - Corporate Strategy
Zydus Cadila Healthcare Limited - SWOT Analysis
SWOT Analysis - Overview
Zydus Cadila Healthcare Limited - Strengths
Strength - Operational Base: Vertical Integration
Strength - Product and Brand Portfolio
Strength - Leading Market Position
Zydus Cadila Healthcare Limited - Weaknesses
Weakness - Weak Operational Efficiency
Weakness - Trade Receivables
Zydus Cadila Healthcare Limited - Opportunities
Opportunity - Investments: New Technologies
Opportunity - Growth Prospects: Emerging Markets
Opportunity - Acquisitions and Agreements
Zydus Cadila Healthcare Limited - Threats
Threat - Competitive Landscape
Threat - Uncertain R&D Activities
Threat - Stringent Government Regulations
Zydus Cadila Healthcare Limited - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
Zydus Cadila Healthcare Limited, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Zydus Cadila Healthcare Limited, Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013
Zydus Cadila Healthcare Limited, Medical Equipment, Deals By Year, 2007 to YTD 2013
Zydus Cadila Healthcare Limited, Medical Equipment, Deals By Type, 2007 to YTD 2013
Zydus Cadila Healthcare Limited, Recent Deals Summary
SECTION 5 – COMPANY’S RECENT DEVELOPMENTS
Zydus Cadila Healthcare Limited, Recent Developments
Feb 08, 2013: Cadila Healthcare Reports Revenue Of INR15.6 Billion In Q3 Fiscal 2013
Nov 07, 2012: Cadila Healthcare Reports Revenue Of INR15.1 Billion In Q2 Fiscal 2013
Aug 06, 2012: Cadila Healthcare Reports Revenue Of INR15.2 Billion In Q1 Fiscal 2013
Jul 17, 2012: FDA Withdraws Earlier Warning Letter Issued To Cadila Healthcare
May 10, 2012: Cadila Healthcare Reports Revenue Of INR13.4 Billion In Q4 Fiscal 2012
Apr 02, 2012: Karo Bio's Collaboration With Zydus Cadila Expires
Feb 07, 2012: Cadila Healthcare Reports Net Sales Of INR13.5 Billion In Q3 Fiscal 2012
SECTION 6 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
LIST OF TABLES
Zydus Cadila Healthcare Limited, Key Facts
Zydus Cadila Healthcare Limited, Key Employees
Zydus Cadila Healthcare Limited, Key Employee Biographies
Zydus Cadila Healthcare Limited, Major Products and Services
Zydus Cadila Healthcare Limited, Number of Pipeline Products by Therapy Area
Zydus Cadila Healthcare Limited, Number of Pipeline Products by Development Stage
Zydus Cadila Healthcare Limited, Pipeline Products By Therapy Area and Development Phase
Zydus Cadila Healthcare Limited, History
Zydus Cadila Healthcare Limited, Subsidiaries
Zydus Cadila Healthcare Limited, Joint Venture
Zydus Cadila Healthcare Limited, Key Competitors
Zydus Cadila Healthcare Limited, Ratios based on current share price
Zydus Cadila Healthcare Limited, Annual Ratios
Zydus Cadila Healthcare Limited, Interim Ratios
Zydus Cadila Healthcare Limited, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Zydus Cadila Healthcare Limited, Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013
Zydus Cadila Healthcare Limited, Medical Equipment, Deals By Year, 2007 to YTD 2013
Zydus Cadila Healthcare Limited, Medical Equipment, Deals By Type, 2007 to YTD 2013
Zydus Cadila Healthcare Limited, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
LIST OF FIGURES
Sarepta Therapeutics, Inc., Pipeline Products by Therapy Area
Sarepta Therapeutics, Inc., Pipeline Products by Development Phase
Sarepta Therapeutics, Inc., Performance Chart (2007 - 2011)
Sarepta Therapeutics, Inc., Ratio Charts
Sarepta Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Sarepta Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2007 to YTD 2013